Pharmaceutical Contract Packaging Market Size:
To get more Pharmaceutical Contract Packaging Market - Request Free Sample Report
The Pharmaceutical Contract Packaging Market was valued at USD 15.30 billion in 2023 and is expected to reach USD 31.56 billion by 2032, growing at a CAGR of 8.33% from 2024-2032.
The pharmaceutical contract packaging market is growing steadily, with the increasing complexity of pharmaceutical formulations and the rising demand for innovative and secure packaging solutions. With the global pharmaceutical industry focusing on biologics, personalized medicine, and specialty drugs, the need for advanced packaging technologies such as pre-filled syringes, blister packs, and tamper-proof solutions has surged significantly.
Other regulatory requirements emphasizing drug safety, anti-counterfeiting measures, and sustainability continue to drive the adoption of specialized packaging services. Smarter packaging solutions, involving RFID tags and QR codes to enhance supply chain transparency, are increasingly being incorporated in contract packaging services.
With the global pharmaceutical industry focusing on biologics, personalized medicine, and specialty drugs, the need for advanced packaging technologies such as pre-filled syringes, blister packs, and tamper-proof solutions has surged significantly.
The trend of outsourcing is propelling the market since pharmaceutical companies would like to reduce operational costs and accelerate product launches. In addition to cost efficiencies, contract packaging provides expertise in navigating complex regulatory landscapes, especially in international markets. Sustainability has also become a critical focus for the market, and providers have adopted eco-friendly materials and processes to align with global environmental goals. These advances and evolving pharmaceutical needs are likely to sustain robust growth in the pharmaceutical contract packaging market. Biologics often require greater standards of sterility and containment, so contract packaging providers are investing in advanced facilities and technologies to meet these requirements.
Market Dynamics
Drivers
Increased demand for biologics and specialty drugs propels the pharmaceutical contract packaging market
The increasing incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has boosted the demand for biologics and specialty drugs, which require advanced and secure packaging solutions. The high sensitivity of biologics and strict temperature control requirements have also increased the adoption of sterile and tamper-evident packaging technologies. For example, injectables are one of the chief delivery methods for biologics and account for more than 40% of pharmaceutical demand for packaging in developed geographies such as North America and Europe. This trend necessitates pharmaceutical companies to transfer packaging operations to specialized contract packaging providers with sufficient infrastructure and expertise.
Strict Packaging Requirements for Drug Safety helps to boost the market growth
Stringent global regulatory requirements regarding the packaging of medicines-often including the US Drug Supply Chain Security Act and EU's Falsified Medicines Directive-will influence a great number of companies towards new-generation packaging solutions due to compliance with serialization requirements, anti-tamper designs, and authentication to make packaging more complex and costly to obtain. For instance, it is estimated that adherence to serialization requirements increased global pharmaceutical packaging costs by as much as 15–20%. Contract packaging providers who offer advanced technological capabilities as well as regulatory expertise are perfectly suited to meet this need thereby fueling market growth.
Restraint
Logistics management challenges and rising costs restraining the pharmaceutical contract packaging market
The increasing operational costs coupled with the complex supply chain management need further challenges the pharmaceutical contract packaging market. The complex interplay between pharmaceutical manufacturers, regulatory authorities and logistics providers leads to repeated delays and waste. Another major factor fuelling the change in prices is the adoption of sophisticated packaging technologies such as serialization and smart packaging that have immensely raised production costs. For instance, the packaging cost of manufacturers may go up by 10–15% approximately. These aspects do not allow such smaller pharma firms to outsource packaging services, thereby restraining the market's growth potential.
Segment Analysis
By Type
In 2023, the primary packaging segment dominated the market with 74% of the market share. This is largely because, of the critical nature of primary packaging for pharmaceuticals due to the need for quality, safety, and compliance with pharmaceutical products. The contact materials, such as blister packs, bottles, vials, and ampoules are essential, as these are needed to maintain the quality and efficacy of the drugs. Primary packaging acts as the first interaction between the drug and the patient; it is thus responsible for ensuring functionality as well as ensuring the safety of the patient and regulatory compliance. All the above factors continue to fuel the demand for primary packaging solutions in the pharmaceutical industry.
The secondary packaging segment will witness substantial growth in the coming years, driven chiefly by the growing emphasis on branding, consumer safety, and regulatory compliance. Secondary packaging encompasses outer protective components like cartons, boxes, labels, and instructional leaflets. It acts as the first shield of defense in transportation, safeguarding the product while providing stability. Furthermore, secondary packaging is also essential for compliance with serialization and traceability requirements, which are increasingly becoming the norm in the fight against counterfeiting as well as increasing transparency in the supply chain.
By Material
The plastics and polymers segment dominated the market and accounted for the highest market share of 39% in 2023. These plastics and polymers have various advantages including their versatility, cost-effectiveness, durability, and ease of manufacturing. Such plastics and polymers are widely used for the production of bottles, blister packs, vials, and ampoules, among other forms of specialized pharmaceutical packaging due to their moldability in any form or shape. The plastic and polymer market can also be tailored to satisfy particular regulatory requirements, such as sterility, tamper-proofing, and child resistance, making them the most popular for chemical and pharmaceutical packaging.
Paper and paperboard are expected to be the fastest growing segment in the market with a CAGR of 11% throughout the forecast period due to growing demand for green and environmentally friendly packaging solutions. With the growing concerns about plastic waste and the need for sustainability, many companies are turning to biodegradable and recyclable materials that minimize environmental impact. Paper and paperboard, being low-cost, versatile, and renewable resources, are emerging as attractive alternatives for secondary packaging, aligning with the global push toward eco-friendly practices.
Regional Analysis
In 2023, the North American pharmaceutical contract packaging market dominated with a market share of 34% of the market. The packaging suppliers of North America are increasingly equipped with advanced technologies that meet the needs of various segments of the pharmaceutical industry, including vaccines, biologics, and advanced therapies. This is managed with all these high-end requirements, expertly professionalized, and backed with hi-tech infrastructure, which consolidates its position its most global leader in pharmaceutical contract packaging in the world.
In 2023, the Asia Pacific pharmaceutical contract packaging market is expected the fastest CAGR of 10.19% during the forecast period by robust public & private emerging trends driving the spur in the pace of technology, rise in healthcare needs, and extensive order outsourcing in services sectors). Competitive pricing and technologies are linked with a large scale of manufacture, which makes the Asia-Pacific region an attractive pharmaceutical hub. Contract packaging is especially important to India, as it holds tremendous potential to create growth through exports to meet global market demands, as well as fulfilling a sizeable share of local domestic market demand.
Get Customized Report as per Your Business Requirement - Enquiry Now
Key Market Players
Catalent, Inc. (Blister Packaging, Bottle Filling Services)
Sharp Packaging Services (Clinical Trial Packaging, Blister Pack Design)
PCI Pharma Services (Secondary Packaging, Serialization Services)
WestRock Company (Folding Cartons, Adherence Packaging Solutions)
Amcor Plc (Child-resistant Blisters, Flexible Pouches)
Gerresheimer AG (Plastic Vials, Syringe Systems)
Aptar Pharma (Nasal Spray Packaging, Metered Dose Inhalers)
Schott AG (Glass Ampoules, Pre-filled Syringes)
CCL Industries Inc. (Pressure-sensitive Labels, Shrink Sleeves)
Baxter International Inc. (Sterile IV Solutions Packaging, Parenteral Packaging
Nelipak Healthcare Packaging (Thermoformed Trays, Blister Packs)
Sonoco Products Company (Composite Cans, Blister Cards)
Romaco Group (Strip Packaging Machines, Sachet Filling Systems)
Vetter Pharma International GmbH (Aseptic Fill and Finish, Prefilled Syringe Packaging)
SGD Pharma (Glass Bottles, Injectable Vials)
West Pharmaceutical Services, Inc. (Injection Systems, Container Closure Systems)
Mondi Group (Medical Barrier Packaging, Laminated Foils)
Sealed Air Corporation (Vacuum Packaging, Sterile Packaging Films)
Körber Pharma Packaging (Blister Lines, Serialization Software)
Nipro Corporation (Glass Cartridges, Rubber Stoppers)
Key suppliers
These suppliers play an essential role in the pharmaceutical contract packaging supply chain by delivering critical materials and components used in developing and producing various packaging solutions.
Berry Global Group, Inc. Suppliers
Tekni-Plex, Inc. Suppliers
Avery Dennison Corporation Suppliers
Alpla Group Suppliers
Constantia Flexibles Group GmbH Suppliers
RPC Group (Berry Global) Supplier
Placon Corporation Suppliers
Bemis Company, Inc. (Amcor) Suppliers
WestRock Healthcare Packaging Suppliers
Klöckner Pentaplast Group Suppliers
Recent Developments
In October 2024, Ardena, a leading pharmaceutical Contract Development and Manufacturing Organization (CDMO) with GMP-certified facilities in Belgium, Spain, the Netherlands, and Sweden, announced the signing of a definitive agreement to acquire Catalent's manufacturing facility located in Somerset, New Jersey.
In May 2024, Sharp, a global leader in contract packaging, clinical supply services, and small-scale sterile manufacturing, revealed plans to expand its Macungie, Pennsylvania site in North America.
In June 2024, PCI Pharma Services, a leading provider of integrated pharmaceutical packaging and clinical trial services, announced its plans to construct a new pharmaceutical packaging facility at the CityNorth Business Campus.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 15.30 Billion |
| Market Size by 2032 | US$ 31.56 Billion |
| CAGR | CAGR of 8.33% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Type (Primary Packaging, Secondary Packaging, Tertiary Packaging) • By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Catalent, Inc., Sharp Packaging Services, PCI Pharma Services, WestRock Company, Amcor Plc, Gerresheimer AG, Aptar Pharma, Schott AG, CCL Industries Inc., Baxter International Inc., Nelipak Healthcare Packaging, Sonoco Products Company, Romaco Group, Vetter Pharma International GmbH, SGD Pharma, West Pharmaceutical Services, Inc., Mondi Group, Sealed Air Corporation, Körber Pharma Packaging, Nipro Corporation, and other players. |
| Key Drivers | •Increased demand for biologics and specialty drugs propels the pharmaceutical contract packaging market •Strict Packaging Requirements for Drug Safety help to the boost the market growth |
| Restraints | •Logistics management challenges and rising costs restraining the pharmaceutical contract packaging market |
Ans- The Pharmaceutical Contract Packaging Market was valued at USD 1.87 billion in 2023 and is expected to reach USD 3.83 billion by 2032.
Ans – The Pharmaceutical Contract Packaging Market's CAGR rate from 2024-2032 is 8.32%.
Ans- The complete denature segment dominated the market by 54%
Ans- North America held the largest revenue share by 35%.
Ans- Asia Pacific is the fastest-growing region in the Pharmaceutical Contract Packaging Market.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
5. Statistical Insights and Trends Reporting
5.1 Market Share by Packaging Type
5.2 Growth Rate by Service Type
5.3 Packaging Material Trends
5.4 Regulatory Compliance and Packaging Standards
5.5 Cost Analysis by Packaging Type
5.6 R&D Investment in Packaging Solutions
5.7 Trends in Sustainable Packaging
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Pharmaceutical Contract Packaging Market Segmentation, by Type
7.1 Chapter Overview
7.2 Primary Packaging
7.2.1 Primary Packaging Market Trends Analysis (2020-2032)
7.2.2 Primary Packaging Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Bottles
7.2.3.1 Bottles Market Trends Analysis (2020-2032)
7.2.3.2 Bottles Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Vials
7.2.4.1 Vials Market Trends Analysis (2020-2032)
7.2.4.2 Vials Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Ampoules
7.2.5.1 Ampoules Market Trends Analysis (2020-2032)
7.2.5.2 Ampoules Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Blister Packs
7.2.6.1 Blister Packs Market Trends Analysis (2020-2032)
7.2.6.2 Blister Packs Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Others
7.2.7.1 Others Market Trends Analysis (2020-2032)
7.2.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Secondary Packaging
7.4.1 Secondary Packaging Market Trends Analysis (2020-2032)
7.4.2 Secondary Packaging Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Tertiary Packaging
7.4.1 Tertiary Packaging Market Trends Analysis (2020-2032)
7.4.2 Tertiary Packaging Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Pharmaceutical Contract Packaging Market Segmentation, by Material
8.1 Chapter Overview
8.2 Plastics & Polymers
8.2.1 Plastics & Polymers Market Trends Analysis (2020-2032)
8.2.2 Plastics & Polymers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Paper & Paperboard
8.3.1 Paper & Paperboard Market Trends Analysis (2020-2032)
8.3.2 Paper & Paperboard Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Aluminum Foil
8.4.1 Aluminum Foil Market Trends Analysis (2020-2032)
8.4.2 Aluminum Foil Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.4 North America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.5.2 USA Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.6.2 Canada Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.6.2 France Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Healthcare Predictive Analytic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 China Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 India Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.5.2 Japan Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Healthcare Predictive Analytic Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.9.2 Australia Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.4 Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.4 Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Pharmaceutical Contract Packaging Market Estimates and Forecasts, by Material (2020-2032) (USD Billion)
10. Company Profiles
10.1 Catalent, Inc.
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Sharp Packaging Services
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 PCI Pharma Services
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 WestRock Company
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Amcor Plc.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Gerresheimer AG
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Aptar Pharma
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Schott AG
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 CCL Industries Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Baxter International Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Primary Packaging
Bottles
Vials
Ampoules
Blister Packs
Others
Secondary Packaging
Tertiary Packaging
by Material
Plastics & Polymers
Paper & Paperboard
Glass
Aluminum Foil
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization to meet the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Pyrogen Testing Market Size was valued at USD 1.60 Billion in 2023 and is expected to reach USD 3.17 Billion by 2032, growing at a CAGR of 7.93% over the forecast period 2024-2032.
The Dry Eye Syndrome Treatment Market was valued at USD 5.86 billion in 2023 and is expected to reach USD 10.17 billion by 2032, growing at a CAGR of 6.32% from 2024-2032.
The Optometry Equipment Market was valued at USD 4.37 billion in 2023 and is expected to reach USD 7.63 billion by 2032, growing at a CAGR of 6.39% from 2024-2032.
The Healthcare BPO Market Size was valued at USD 380.8 Bn in 2023 and is expected to reach USD 873.8 Bn by 2031 and grow at a CAGR of 9.71% by 2024-2032.
The Foot Orthotic Insoles Market was valued at USD 3.78 Billion in 2023 and is projected to reach USD 6.87 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.93% from 2024 to 2032.
The Type 1 Diabetes Market Size was valued at USD 32.3 billion in 2023 and is expected to reach $63.5 billion by 2032 and grow at a CAGR of 7.82% by 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
